![](/img/cover-not-exists.png)
1353PCNS response to osimertinib in Asian-Pacific patients (pts) with T790M-positive advanced NSCLC: data from an open-label Phase II trial (AURA17)
Zhou, C., Cheng, Y., Lu, Y., Shi, M., Han, J-Y., Wang, M., Kim, S-W., Wang, J., Chen, Y., Wu, Y-L.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx380.055
Date:
September, 2017
File:
PDF, 50 KB
english, 2017